Has beta-blocker use increased in patients with heart failure in internal medicine settings? Prognostic implications: RICA registry

Andrés González-García, Manuel Montero Pérez-Barquero, Francesc Formiga, José R. González-Juanatey, M. Angustias Quesada, Francisco Epelde, Roberto Oropesa, Jesús Díez-Manglano, José M. Cerqueiro, Luis Manzano

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)


Introduction and objectives Underuse of beta-blockers has been reported in elderly patients with heart failure. The aim of this study was to evaluate the current prescription of beta-blockers in the internal medicine setting, and its association with morbidity and mortality in heart failure patients. Methods The information analyzed was obtained from a prospective cohort of patients hospitalized for heart failure (RICA registry database, patients included from March 2008 to September 2011) with at least one year of follow-up. We investigated the percentage of patients prescribed beta-blockers at hospital discharge, and at 3 and 12 months, and the relationship of beta-blocker use with mortality and readmissions for heart failure. Patients with significant valve disease were excluded. Results A total of 515 patients were analyzed (53.5% women), with a mean age of 77.1 (8.7) years. Beta-blockers were prescribed in 62.1% of patients at discharge. A similar percentage was found at 3 months (65.6%) and 12 months (67.9%) after discharge. All-cause mortality and the composite of all-cause mortality and readmission for heart failure were significantly lower in patients treated with beta-blockers (hazard ratio=0.59, 95% confidence interval, 0.41-0.84 vs hazard ratio=0.64, 95% confidence interval, 0.49-0.83). This decrease in mortality was maintained after adjusting by age, sex, ejection fraction, functional class, comorbidities, and concomitant treatment. Conclusions The findings of this study indicate that beta-blocker use is increasing in heart failure patients (mainly elderly) treated in the internal medicine setting, and suggest that the use of these drugs is associated with a reduction in clinical events. © 2013 Sociedad Española de Cardiología. Publicado por Elsevier España, S.L. Todos los derechos reservados.
Original languageEnglish
Pages (from-to)196-202
JournalRevista Espanola de Cardiologia
Issue number3
Publication statusPublished - 1 Mar 2014


  • Beta-blocker agents
  • Elderly
  • Heart failure
  • RICA registry
  • Treatment


Dive into the research topics of 'Has beta-blocker use increased in patients with heart failure in internal medicine settings? Prognostic implications: RICA registry'. Together they form a unique fingerprint.

Cite this